SCHEMBL30097100

SCHEMBL30097100

C[C@H](NC(=O)CNC(=O)C(=O)[C@@H](N)Cc1ccccc1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 2/20 0.61
RNPEP Q9H4A4 1/20 0.61
DNPEP Q9ULA0 1/20 0.61
LTA4H P09960 4/20 0.58
OPRD1 P41143 5/20 0.51
OPRM1 P35372 4/20 0.51
OPRK1 P41145 1/20 0.51
ALPI P09923 1/20 0.49
PKM P14618 1/20 0.49
PTGS1 P23219 1/20 0.49
XIAP P98170 1/20 0.49
SLC7A5 Q01650 1/20 0.49
MME P08473 2/20 0.47
ECE1 P42892 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29434570 0.87 OPRD1 (0.61) ANPEPLTA4HOPRD1OPRM1OPRK1
SCHEMBL29613015 0.84 ANPEP (0.52) ANPEPRNPEPDNPEPLTA4HOPRD1
SCHEMBL29613062 0.81 LTA4H (0.53) ANPEPRNPEPDNPEPLTA4HOPRD1
SCHEMBL29613047 0.81 ANPEP (0.51) ANPEPRNPEPDNPEPLTA4HOPRD1
SCHEMBL29613235 0.80 OPRD1 (0.57) ANPEPRNPEPDNPEPOPRD1OPRM1
SCHEMBL1711542 0.78 LTA4H (0.64) ANPEPLTA4HALPIPKMPTGS1
SCHEMBL11113147 0.78 LTA4H (0.64) ANPEPLTA4HALPIPKMPTGS1
SCHEMBL7347389 0.78 ANPEP (0.69) ANPEPRNPEPDNPEPLTA4HALPI
SCHEMBL8494890 0.78 ANPEP (0.69) ANPEPRNPEPDNPEPLTA4HALPI
SCHEMBL8787479 0.78 LTA4H (0.64) ANPEPLTA4HALPIPKMPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250295120-A1 CLEANING METHOD, USE OF ENZYMES AND CLEANING COMPOSITION NOVOZYMES A/S (DK) 2025-09-25 US disclosed
US-20250084346-A1 ENCAPSULATED SOLID ENZYME PRODUCT NOVOZYMES A/S (DK) 2025-03-13 US disclosed
US-20240301328-A1 POLYPEPTIDE VARIANTS NOVOZYMES A/S (DK) 2024-09-12 US disclosed
CN-118632931-A Cleaning method, use of enzymes and cleaning composition 诺维信公司 2024-09-10 CN disclosed
US-12060542-B2 Polypeptides and compositions comprising such polypeptides NOVOZYMES A/S (DK) 2024-08-13 US disclosed
EP-4379029-A1 POLYPEPTIDES AND COMPOSITIONS COMPRISING SUCH POLYPEPTIDES Novozymes A/S (DK) 2024-06-05 EP disclosed
EP-3647398-B1 CLEANING COMPOSITIONS CONTAINING DISPERSINS V HENKEL AG & CO KGAA (DE) 2024-05-15 EP disclosed
US-20240010955-A1 Polypeptides and Compositions Comprising Such Polypeptides NOVOZYMES A/S (DK) 2024-01-11 US disclosed
EP-3704219-B1 POLYPEPTIDES AND COMPOSITIONS COMPRISING SUCH POLYPEPTIDES NOVOZYMES AS (DK) 2024-01-10 EP disclosed
US-11767492-B2 Methods of treating fabric using a Lactobacillus hexosaminidase NOVOZYMES A/S (DK) 2023-09-26 US disclosed
US-20220411773-A1 POLYPEPTIDES HAVING PROTEOLYTIC ACTIVITY AND USE THEREOF NOVOZYMES A/S (DK) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250295120-A1 CLEANING METHOD, USE OF ENZYMES AND CLEANING COMPOSITION DNASE1, HEXD, HEXA ANPEP 45/4885RNPEP 27/4885DNPEP 63/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.